BTK Inhibitor DTRMWXHS-12 in Mantle Cell Lymphoma

Clinical trial NCT03836768 · COMPLETED

Trial details

NCT number: NCT03836768
Sponsor: Zhejiang DTRM Biopharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Mantle Cell Lymphoma

Start date: 2019-01-11
Primary completion: 2021-11-17
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.